ARCHIVES

In Brief: Hatch Bill Would Require NDA Sponsors To Pay Fee; IND, Generic Drug NDAs Would Be Exempt

This article is from The Cancer Letter archive.

Vol. 12 No. 34 | August 22, 1986

Download PDF Visit The Full Archive

Related Articles

Is Everyone in Academic Medicine Unhappy? Or is it Just MD Anderson?

December 12, 2014

B-27 Finds Improved CR For Taxotere Prior To Surgery

November 28, 2003

Hawaiian Have Highest Cancer Rate In U.S.

April 29, 1983

PET/CT Imaging During Treatment Shows Whether Chemo Is Working, Study Finds

April 24, 2009

Ruckdeschel To Direct Nevada Cancer Institute

February 6, 2009

Legacy CEO Cheryl Healton says foundation could serve as funder for research on “potentially reduced-exposure products.”

October 29, 2004